Neupogen (filgrastim, G-CSF) to treat diabetic foot infections

December 1997

Researchers are now trying Neupogen (filgrastim, G-CSF) to treat diabetic foot infections.

This is very preliminary...but initial results look promising.

Neupogen is usually given to increase the PRODUCTION of neutrophils. In this situation, it's used to improve their FUNCTION.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote